Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine dose optimization for laryngeal mask airway insertion with propofol in pediatric surgery
ChiCTR-IPR-16008271Phase 4Not yet recruiting
- Sponsor
- Shengjing Hospital of China Medical University
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine and propofol (3 arms), sponsored by Shengjing Hospital of China Medical University. Primary endpoint: LMA insertion score. Planned start May 2016; status: not yet recruiting.
02
Drugs
ketaminepropofol
Beyond the preview
Go deeper on ChiCTR-IPR-16008271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008271.